Fungal PDR transporters: Phylogeny, topology, motifs and function

Fungal Genetics and Biology

Volumn 47, Issue 2, 2010, Pages 127-142

  Lamping, Erwin ^a   Baret, Philippe V ^b   Holmes, Ann R ^a   Monk, Brian C ^a   Goffeau, Andre ^b   Cannon, Richard D ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Antifungal; ATP binding cassette (ABC); Azoles; Multidrug resistance (MDR); PDR motif A; PDR motif B; Pleiotropic drug resistance (PDR)

Indexed keywords

ABC TRANSPORTER; AMPHOTERICIN B; CARRIER PROTEIN; FLUCONAZOLE; FLUCYTOSINE; FUNGAL PROTEIN; ITRACONAZOLE; MAJOR FACILITATOR SUPERFAMILY PROTEIN; PLEIOTROPIC DRUG RESISTANCE PROTEIN; PYRROLE DERIVATIVE; UNCLASSIFIED DRUG; VORICONAZOLE;

ALPHA HELIX; AMINO ACID SEQUENCE; ANTIFUNGAL RESISTANCE; ARTICLE; ASPERGILLOSIS; BETA SHEET; BINDING SITE; CANDIDIASIS; CRYPTOCOCCAL MENINGITIS; CRYPTOCOCCOSIS; GENETIC CONSERVATION; HUMAN; MEMBRANE TRANSPORT; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; TRANSPORT KINETICS;

AMINO ACID MOTIFS; ANTIFUNGAL AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; DNA-BINDING PROTEINS; DRUG RESISTANCE, FUNGAL; DRUG RESISTANCE, MULTIPLE; FUNGAL PROTEINS; FUNGI; HUMANS; PHYLOGENY;

EID: 73749088513     PISSN: 10871845     EISSN: 10960937     Source Type: Journal    
DOI: 10.1016/j.fgb.2009.10.007     Document Type: Article

References (125)

1. Akins R.A. An update on antifungal targets and mechanisms of resistance in Candida albicans. Med. Mycol. 43 4 (2005) 285-318
2. Aller S.G., Yu J., Ward A., Weng Y., Chittaboina S., et al. Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding. Science 323 5922 (2009) 1718-1722
3. Balzi E., Wang M., Leterme S., Van Dyck L., and Goffeau A. PDR5, a novel yeast multidrug resistance conferring transporter controlled by the transcription regulator PDR1. J. Biol. Chem. 269 3 (1994) 2206-2214
4. Bauer B.E., Wolfger H., and Kuchler K. Inventory and function of yeast ABC proteins: about sex, stress, pleiotropic drug and heavy metal resistance. Biochim. Biophys. Acta 1461 2 (1999) 217-236
5. Bennett J.E., Izumikawa K., and Marr K.A. Mechanism of increased fluconazole resistance in Candida glabrata during prophylaxis. Antimicrob. Agents Chemother. 48 5 (2004) 1773-1777
6. Bouige P., Laurent D., Piloyan L., and Dassa E. Phylogenetic and functional classification of ATP-binding cassette (ABC) systems. Curr. Protein Pept. Sci. 3 5 (2002) 541-559
7. Cannon R.D., Holmes A.R., Mason A.B., and Monk B.C. Oral Candida: clearance, colonization, or candidiasis?. J. Dent. Res. 74 5 (1995) 1152-1161
8. Cannon R.D., Lamping E., Holmes A.R., Niimi K., Baret P.V., et al. Efflux-mediated antifungal drug resistance. Clin. Microbiol. Rev. 22 2 (2009) 291-321
9. Chang G. Structure of MsbA from Vibrio cholera: a multidrug resistance ABC transporter homolog in a closed conformation. J. Mol. Biol. 330 2 (2003) 419-430
10. Chen J., Li H., Li R., Bu D., and Wan Z. Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma. J. Antimicrob. Chemother. 55 1 (2005) 31-37
11. Corbett E.L., Churchyard G.J., Charalambos S., Samb B., Moloi V., et al. Morbidity and mortality in South African gold miners: impact of untreated disease due to human immunodeficiency virus. Clin. Infect. Dis. 34 9 (2002) 1251-1258
12. Crouzet J., Trombik T., Fraysse A.S., and Boutry M. Organization and function of the plant pleiotropic drug resistance ABC transporter family. FEBS Lett. 580 4 (2006) 1123-1130
13. da Silva Ferreira M.E., Capellaro J.L., dos Reis Marques E., Malavazi I., Perlin D., et al. In vitro evolution of itraconazole resistance in Aspergillus fumigatus involves multiple mechanisms of resistance. Antimicrob. Agents Chemother. 48 11 (2004) 4405-4413
14. Dassa E., and Bouige P. The ABC of ABCS: a phylogenetic and functional classification of ABC systems in living organisms. Res. Microbiol. 152 3-4 (2001) 211-229
15. Davies A.N., Brailsford S.R., and Beighton D. Oral candidosis in patients with advanced cancer. Oral Oncol. 42 7 (2006) 698-702
16. Dawson R.J., and Locher K.P. Structure of a bacterial multidrug ABC transporter. Nature 443 7108 (2006) 180-185
17. de Repentigny L., Lewandowski D., and Jolicoeur P. Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection. Clin. Microbiol. Rev. 17 4 (2004) 729-759 (table of contents)
18. Dean, M., 2002. The Human ATP-Binding Cassette (ABC) Transporter Superfamily: NCBI; Available Online at the NCBI Bookshelf: , 50 p.
19. Decottignies A., and Goffeau A. Complete inventory of the yeast ABC proteins. Nat. Genet. 15 2 (1997) 137-145
20. Dujon B., Sherman D., Fischer G., Durrens P., Casaregola S., et al. Genome evolution in yeasts. Nature 430 6995 (2004) 35-44
21. Edgar R., and Bibi E. A single membrane-embedded negative charge is critical for recognizing positively charged drugs by the Escherichia coli multidrug resistance protein MdfA. Embo. J. 18 4 (1999) 822-832
22. Egner R., Bauer B.E., and Kuchler K. The transmembrane domain 10 of the yeast Pdr5p ABC antifungal efflux pump determines both substrate specificity and inhibitor susceptibility. Mol. Microbiol. 35 5 (2000) 1255-1263
23. Ernst R., Kueppers P., Klein C.M., Schwarzmueller T., Kuchler K., et al. A mutation of the H-loop selectively affects rhodamine transport by the yeast multidrug ABC transporter Pdr5. Proc. Natl. Acad. Sci. USA 105 13 (2008) 5069-5074
24. Ferreira M.E., Colombo A.L., Paulsen I., Ren Q., Wortman J., et al. The ergosterol biosynthesis pathway, transporter genes, and azole resistance in Aspergillus fumigatus. Med. Mycol. 43 Suppl. 1 (2005) S313-319
25. Ferreira-Pereira A., Marco S., Decottignies A., Nader J., Goffeau A., et al. Three-dimensional reconstruction of the Saccharomyces cerevisiae multidrug resistance protein Pdr5p. J. Biol. Chem. 278 14 (2003) 11995-11999
26. Finn R.D., Tate J., Mistry J., Coggill P.C., Sammut S.J., et al. The Pfam protein families database. Nucleic Acids Res. 36 Database issue (2008) D281-D288
27. Gafvelin G., Sakaguchi M., Andersson H., and von Heijne G. Topological rules for membrane protein assembly in eukaryotic cells. J. Biol. Chem. 272 10 (1997) 6119-6127
28. Gao M., Cui H.R., Loe D.W., Grant C.E., Almquist K.C., et al. Comparison of the functional characteristics of the nucleotide binding domains of multidrug resistance protein 1. J. Biol. Chem. 275 17 (2000) 13098-13108
29. Gaur M., Choudhury D., and Prasad R. Complete inventory of ABC proteins in human pathogenic yeast, Candida albicans. J. Mol. Microbiol. Biotechnol. 9 1 (2005) 3-15
30. Gauthier C., Weber S., Alarco A.M., Alqawi O., Daoud R., et al. Functional similarities and differences between Candida albicans Cdr1p and Cdr2p transporters. Antimicrob. Agents Chemother. 47 5 (2003) 1543-1554
31. Gbelska Y., Krijger J.J., and Breunig K.D. Evolution of gene families: the multidrug resistance transporter genes in five related yeast species. FEMS Yeast Res. 6 3 (2006) 345-355
32. Goffeau A., Barrell B.G., Bussey H., Davis R.W., Dujon B., et al. Life with 6000 genes. Science 274 5287 (1996) 546-563 547
33. Hartmann E., Rapoport T.A., and Lodish H.F. Predicting the orientation of eukaryotic membrane-spanning proteins. Proc. Natl. Acad. Sci. USA 86 15 (1989) 5786-5790
34. Henriksen U., Fog J.U., Litman T., and Gether U. Identification of intra- and intermolecular disulfide bridges in the multidrug resistance transporter ABCG2. J. Biol. Chem. 280 44 (2005) 36926-36934
35. Herget M., Oancea G., Schrodt S., Karas M., Tampe R., et al. Mechanism of substrate sensing and signal transmission within an ABC transporter: use of a Trojan horse strategy. J. Biol. Chem. 282 6 (2007) 3871-3880
36. Higgins C.F. ABC transporters: physiology, structure and mechanism - an overview. Res. Microbiol. 152 3-4 (2001) 205-210
37. Higgins C.F. Multiple molecular mechanisms for multidrug resistance transporters. Nature 446 7137 (2007) 749-757
38. Higgins C.F., and Linton K.J. The ATP switch model for ABC transporters. Nat. Struct. Mol. Biol. 11 10 (2004) 918-926
39. Holland I.B., and Blight M.A. ABC-ATPases, adaptable energy generators fuelling transmembrane movement of a variety of molecules in organisms from bacteria to humans. J. Mol. Biol. 293 2 (1999) 381-399
40. Hollenstein K., Dawson R.J., and Locher K.P. Structure and mechanism of ABC transporter proteins. Curr. Opin. Struct. Biol. 17 4 (2007) 412-418
41. Holmes A.R., Lin Y.H., Niimi K., Lamping E., Keniya M., et al. ABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates. Antimicrob. Agents Chemother. 52 11 (2008) 3851-3862
42. Holmes A.R., Tsao S., Ong S.W., Lamping E., Niimi K., et al. Heterozygosity and functional allelic variation in the Candida albicans efflux pump genes CDR1 and CDR2. Mol. Microbiol. 62 1 (2006) 170-186
43. Izumikawa K., Kakeya H., Tsai H.F., Grimberg B., and Bennett J.E. Function of Candida glabrata ABC transporter gene, PDH1. Yeast (Chichester, England) 20 3 (2003) 249-261
44. James T.Y., Kauff F., Schoch C.L., Matheny P.B., Hofstetter V., et al. Reconstructing the early evolution of Fungi using a six-gene phylogeny. Nature 443 7113 (2006) 818-822
45. Jasinski M., Ducos E., Martinoia E., and Boutry M. The ATP-binding cassette transporters: structure, function, and gene family comparison between rice and Arabidopsis. Plant Physiol. 131 3 (2003) 1169-1177
46. Jha S., Karnani N., Lynn A.M., and Prasad R. Covalent modification of cysteine 193 impairs ATPase function of nucleotide-binding domain of a Candida drug efflux pump. Biochem. Biophys. Res. Commun. 310 3 (2003) 869-875
47. Jha S., Karnani N., Dhar S.K., Mukhopadhayay K., Shukla S., et al. Purification and characterization of the N-terminal nucleotide binding domain of an ABC drug transporter of Candida albicans: uncommon cysteine 193 of Walker A is critical for ATP hydrolysis. Biochemistry 42 36 (2003) 10822-10832
48. Jones P.M., and George A.M. The ABC transporter structure and mechanism: perspectives on recent research. Cell. Mol. Life Sci. 61 6 (2004) 682-699
49. Jones P.M., O'Mara M.L., and George A.M. ABC transporters: a riddle wrapped in a mystery inside an enigma. Trends Biochem. Sci. 34 10 (2009) 520-531
50. Kanafani Z.A., and Perfect J.R. Antimicrobial resistance: resistance to antifungal agents: mechanisms and clinical impact. Clin. Infect. Dis. 46 1 (2008) 120-128
51. Katiyar S.K., and Edlind T.D. Identification and expression of multidrug resistance-related ABC transporter genes in Candida krusei. Med. Mycol. 39 1 (2001) 109-116
52. Kolaczkowski M., Kolaczowska A., Luczynski J., Witek S., and Goffeau A. In vivo characterization of the drug resistance profile of the major ABC transporters and other components of the yeast pleiotropic drug resistance network. Microb. Drug Resist. 4 3 (1998) 143-158
53. Kontoyiannis D.P., and Lewis R.E. Antifungal drug resistance of pathogenic fungi. Lancet 359 9312 (2002) 1135-1144
54. Kontoyiannis D.P., and Bodey G.P. Invasive aspergillosis in 2002: an update. Eur. J. Clin. Microbiol. Infect. Dis. 21 3 (2002) 161-172
55. Kontoyiannis D.P., Vaziri I., Hanna H.A., Boktour M., Thornby J., et al. Risk factors for Candida tropicalis fungemia in patients with cancer. Clin. Infect. Dis. 33 10 (2001) 1676-1681
56. Kontoyiannis D.P., Lionakis M.S., Lewis R.E., Chamilos G., Healy M., et al. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. J. Infect. Dis. 191 8 (2005) 1350-1360
57. Kralli A., and Yamamoto K.R. An FK506-sensitive transporter selectively decreases intracellular levels and potency of steroid hormones. J. Biol. Chem. 271 29 (1996) 17152-17156
58. Kuhn D.M., Chandra J., Mukherjee P.K., and Ghannoum M.A. Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infect. Immun. 70 2 (2002) 878-888
59. Lai C.C., Tan C.K., Huang Y.T., Shao P.L., and Hsueh P.R. Current challenges in the management of invasive fungal infections. J. Infect. Chemother. 14 2 (2008) 77-85
60. Lamping E., Ranchod A., Nakamura K., Tyndall J.D., Niimi K., et al. Abc1p is a multidrug efflux transporter that tips the balance in favor of innate azole resistance in Candida krusei. Antimicrob. Agents Chemother. 53 2 (2009) 354-369
61. Lamping E., Monk B.C., Niimi K., Holmes A.R., Tsao S., et al. Characterization of three classes of membrane proteins involved in fungal azole resistance by functional hyperexpression in Saccharomyces cerevisiae. Eukaryot. Cell 6 7 (2007) 1150-1165
62. Li Y., and Prinz W.A. ATP-binding cassette (ABC) transporters mediate nonvesicular, raft-modulated sterol movement from the plasma membrane to the endoplasmic reticulum. J. Biol. Chem. 279 43 (2004) 45226-45234
63. Lin X., and Heitman J. The biology of the Cryptococcus neoformans species complex. Annu. Rev. Microbiol. 60 (2006) 69-105
64. Linton K.J., and Higgins C.F. The Escherichia coli ATP-binding cassette (ABC) proteins. Mol. Microbiol. 28 1 (1998) 5-13
65. Locher K.P., Lee A.T., and Rees D.C. The E. coli BtuCD structure: a framework for ABC transporter architecture and mechanism. Science 296 5570 (2002) 1091-1098
66. Loftus B.J., Fung E., Roncaglia P., Rowley D., Amedeo P., et al. The genome of the basidiomycetous yeast and human pathogen Cryptococcus neoformans. Science 307 5713 (2005) 1321-1324
67. Maebashi K., Niimi M., Kudoh M., Fischer F.J., Makimura K., et al. Mechanisms of fluconazole resistance in Candida albicans isolates from Japanese AIDS patients. J. Antimicrob. Chemother. 47 5 (2001) 527-536
68. Mellado E., Diaz-Guerra T.M., Cuenca-Estrella M., and Rodriguez-Tudela J.L. Identification of two different 14-alpha sterol demethylase-related genes (cyp51A and cyp51B) in Aspergillus fumigatus and other Aspergillus species. J. Clin. Microbiol. 39 7 (2001) 2431-2438
69. Mellado E., Garcia-Effron G., Buitrago M.J., Alcazar-Fuoli L., Cuenca-Estrella M., et al. Targeted gene disruption of the 14-alpha sterol demethylase (cyp51A) in Aspergillus fumigatus and its role in azole drug susceptibility. Antimicrob. Agents Chemother. 49 6 (2005) 2536-2538
70. Miyazaki H., Miyazaki Y., Geber A., Parkinson T., Hitchcock C., et al. Fluconazole resistance associated with drug efflux and increased transcription of a drug transporter gene, PDH1, in Candida glabrata. Antimicrob. Agents Chemother. 42 7 (1998) 1695-1701
71. Monk B.C., and Goffeau A. Outwitting multidrug resistance to antifungals. Science 321 5887 (2008) 367-369
72. Muth T.R., and Schuldiner S. A membrane-embedded glutamate is required for ligand binding to the multidrug transporter EmrE. EMBO J. 19 2 (2000) 234-240
73. Nakamura T., Liu Y., Hirata D., Namba H., Harada S., et al. Protein phosphatase type 2B (calcineurin)-mediated, FK506-sensitive regulation of intracellular ions in yeast is an important determinant for adaptation to high salt stress conditions. EMBO J. 12 11 (1993) 4063-4071
74. Nakayama H., Tanabe K., Bard M., Hodgson W., Wu S., et al. The Candida glabrata putative sterol transporter gene CgAUS1 protects cells against azoles in the presence of serum. J. Antimicrob. Chemother. 60 6 (2007) 1264-1272
75. Nascimento A.M., Goldman G.H., Park S., Marras S.A., Delmas G., et al. Multiple resistance mechanisms among Aspergillus fumigatus mutants with high-level resistance to itraconazole. Antimicrob. Agents Chemother. 47 5 (2003) 1719-1726
76. Nierman W.C., Pain A., Anderson M.J., Wortman J.R., Kim H.S., et al. Genomic sequence of the pathogenic and allergenic filamentous fungus Aspergillus fumigatus. Nature 438 7071 (2005) 1151-1156
77. Odds F.C. Candida and Candidosis (1979), Leicester University Press, Leicester 382 p
78. Odds F.C., Brown A.J., and Gow N.A. Antifungal agents: mechanisms of action. Trends Microbiol. 11 6 (2003) 272-279
79. Pasqualotto A.C., and Denning D.W. New and emerging treatments for fungal infections. J. Antimicrob. Chemother. 61 Suppl. 1 (2008) i19-i30
80. Perea S., Lopez-Ribot J.L., Kirkpatrick W.R., McAtee R.K., Santillan R.A., et al. Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients. Antimicrob. Agents Chemother. 45 10 (2001) 2676-2684
81. Pfaller M.A., and Diekema D.J. Epidemiology of invasive candidiasis: a persistent public health problem. Clin. Microbiol. Rev. 20 1 (2007) 133-163
82. Pfaller M.A., Pappas P.G., and Wingard J.R. Invasive fungal pathogens: current epidemiological trends. Clin. Infect. Dis. 43 (2006) S3-14
83. Pfaller M.A., Diekema D.J., Gibbs D.L., Newell V.A., Nagy E., et al. Candida krusei, a multidrug-resistant opportunistic fungal pathogen: geographic and temporal trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005. J. Clin. Microbiol. 46 2 (2008) : 515-521
84. Posteraro B., Sanguinetti M., Sanglard D., La Sorda M., Boccia S., et al. Identification and characterization of a Cryptococcus neoformans ATP binding cassette (ABC) transporter-encoding gene, CnAFR1, involved in the resistance to fluconazole. Mol. Microbiol. 47 2 (2003) 357-371
85. Prasad R., Gaur N.A., Gaur M., and Komath S.S. Efflux pumps in drug resistance of Candida. Infect. Disord. Drug Targets 6 2 (2006) 69-83
86. Purnelle B., Skala J., and Goffeau A. The product of the YCR105 gene located on the chromosome III from Saccharomyces cerevisiae presents homologies to ATP-dependent permeases. Yeast 7 8 (1991) 867-872
87. Rai V., Shukla S., Jha S., Komath S.S., and Prasad R. Functional characterization of N-terminal nucleotide binding domain (NBD-1) of a major ABC drug transporter Cdr1p of Candida albicans: uncommon but conserved Trp326 of Walker B is important for ATP binding. Biochemistry 44 17 (2005) 6650-6661
88. Rees D.C., Johnson E., and Lewinson O. ABC transporters: the power to change. Nat. Rev. Mol. Cell Biol. 10 3 (2009) 218-227
89. Rogers P.D., and Barker K.S. Genome-wide expression profile analysis reveals coordinately regulated genes associated with stepwise acquisition of azole resistance in Candida albicans clinical isolates. Antimicrob. Agents Chemother. 47 4 (2003) 1220-1227
90. Rost B., Yachdav G., and Liu J. The predictprotein server. Nucleic Acids Res. 32 Web Server issue (2004) W321-W326
91. Saag M.S., Graybill R.J., Larsen R.A., Pappas P.G., Perfect J.R., et al. Practice guidelines for the management of cryptococcal disease. Infectious diseases society of America. Clin. Infect. Dis. 30 4 (2000) 710-718
92. Saini P., Prasad T., Gaur N.A., Shukla S., Jha S., et al. Alanine scanning of transmembrane helix 11 of Cdr1p ABC antifungal efflux pump of Candida albicans: identification of amino acid residues critical for drug efflux. J. Antimicrob. Chemother. 56 1 (2005) 77-86
93. Sanglard D., and Bille J. Current understanding of the modes of action of and resistance mechanisms to conventional and emerging antifungal agents for treatment of Candida infections. In: Calderone R.A. (Ed). Candida and Candidiasis (2002), ASM Press, Washington, DC 349-383
94. Sanglard D., Ischer F., and Bille J. Role of ATP-binding-cassette transporter genes in high-frequency acquisition of resistance to azole antifungals in Candida glabrata. Antimicrob. Agents Chemother. 45 4 (2001) 1174-1183
95. Sanglard D., Ischer F., Calabrese D., Majcherczyk P.A., and Bille J. The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents. Antimicrob. Agents Chemother. 43 11 (1999) 2753-2765
96. Sanglard D., Kuchler K., Ischer F., Pagani J.L., Monod M., et al. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob. Agents Chemother. 39 11 (1995) 2378-2386
97. Sanguinetti M., Posteraro B., La Sorda M., Torelli R., Fiori B., et al. Role of AFR1, an ABC transporter-encoding gene, in the in vivo response to fluconazole and virulence of Cryptococcus neoformans. Infect. Immun. 74 2 (2006) 1352-1359
98. Sarvikivi E., Lyytikainen O., Soll D.R., Pujol C., Pfaller M.A., et al. Emergence of fluconazole resistance in a Candida parapsilosis strain that caused infections in a neonatal intensive care unit. J. Clin. Microbiol. 43 6 (2005) 2729-2735
99. Sauna Z.E., Bohn S.S., Rutledge R., Dougherty M.P., Cronin S., et al. Mutations define cross-talk between the N-terminal nucleotide-binding domain and transmembrane helix-2 of the yeast multidrug transporter Pdr5: possible conservation of a signaling interface for coupling ATP hydrolysis to drug transport. J. Biol. Chem. 283 50 (2008) 35010-35022
100. Saurin W., Hofnung M., and Dassa E. Getting in or out: early segregation between importers and exporters in the evolution of ATP-binding cassette (ABC) transporters. J. Mol. Evol. 48 1 (1999) 22-41
101. Schneider E., and Hunke S. ATP-binding-cassette (ABC) transport systems: functional and structural aspects of the ATP-hydrolyzing subunits/domains. FEMS Microbiol. Rev. 22 1 (1998) 1-20
102. Schumacher M.A., and Brennan R.G. Deciphering the molecular basis of multidrug recognition: crystal structures of the Staphylococcus aureus multidrug binding transcription regulator QacR. Res. Microbiol. 154 2 (2003) 69-77
103. Shahi P., and Moye-Rowley W.S. Coordinate control of lipid composition and drug transport activities is required for normal multidrug resistance in fungi. Biochim. Biophys. Acta 1794 5 (2009) 852-859
104. Shao P.L., Huang L.M., and Hsueh P.R. Recent advances and challenges in the treatment of invasive fungal infections. Int. J. Antimicrob. Agents 30 6 (2007) 487-495
105. Shukla S., Saini P., Smriti, Jha S., Ambudkar S.V., et al. Functional characterization of Candida albicans ABC transporter Cdr1p. Eukaryot. Cell 2 6 (2003) 1361-1375
106. Silveira F.P., and Husain S. Fungal infections in solid organ transplantation. Med. Mycol. 45 4 (2007) 305-320
107. Singh N., and Paterson D.L. Aspergillus infections in transplant recipients. Clin. Microbiol. Rev. 18 1 (2005) 44-69
108. Sobel J.D. Vulvovaginal candidosis. Lancet 369 9577 (2007) 1961-1971
109. Strausbaugh L.J., Sewell D.L., Ward T.T., Pfaller M.A., Heitzman T., et al. High frequency of yeast carriage on hands of hospital personnel. J. Clin. Microbiol. 32 9 (1994) 2299-2300
110. Taglicht D., and Michaelis S. Saccharomyces cerevisiae ABC proteins and their relevance to human health and disease. Methods Enzymol. 292 (1998) 130-162
111. Tanaka A.R., Ikeda Y., Abe-Dohmae S., Arakawa R., Sadanami K., et al. Human ABCA1 contains a large amino-terminal extracellular domain homologous to an epitope of Sjogren's syndrome. Biochem. Biophys. Res. Commun. 283 5 (2001) 1019-1025
112. Thornewell S.J., Peery R.B., and Skatrud P.L. Cloning and characterization of CneMDR1: a Cryptococcus neoformans gene encoding a protein related to multidrug resistance proteins. Gene 201 1-2 (1997) 21-29
113. Tsao S., Rahkhoodaee F., and Raymond M. Relative contributions of the Candida albicans ABC transporters Cdr1p and Cdr2p to clinical azole resistance. Antimicrob. Agents Chemother. 53 4 (2009) 1344-1352
114. Tusnady G.E., Sarkadi B., Simon I., and Varadi A. Membrane topology of human ABC proteins. FEBS Lett. 580 4 (2006) 1017-1022
115. Tutulan-Cunita A.C., Mikoshi M., Mizunuma M., Hirata D., and Miyakawa T. Mutational analysis of the yeast multidrug resistance ABC transporter Pdr5p with altered drug specificity. Genes Cells 10 5 (2005) 409-420
116. van den Brule S., and Smart C.C. The plant PDR family of ABC transporters. Planta 216 1 (2002) 95-106
117. Verrier P.J., Bird D., Burla B., Dassa E., Forestier C., et al. Plant ABC proteins - a unified nomenclature and updated inventory. Trends Plant Sci. 13 4 (2008) 151-159
118. von Heijne G. Membrane protein assembly: rules of the game. Bioessays 17 1 (1995) 25-30
119. Wada S., Tanabe K., Yamazaki A., Niimi M., Uehara Y., et al. Phosphorylation of Candida glabrata ATP-binding cassette transporter Cdr1p regulates drug efflux activity and ATPase stability. J. Biol. Chem. 280 1 (2005) 94-103
120. Wang N., Silver D.L., Costet P., and Tall A.R. Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1. J. Biol. Chem. 275 42 (2000) 33053-33058
121. White T.C. Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus. Antimicrob. Agents Chemother. 41 7 (1997) 1482-1487
122. White T.C., Marr K.A., and Bowden R.A. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin. Microbiol. Rev. 11 2 (1998) 382-402
123. Wilson J. The aetiology, diagnosis and management of denture stomatitis. Br. Dent. J. 185 8 (1998) : 380-384
124. Wingard J.R. Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin. Infect. Dis. 20 1 (1995) : 115-125
125. Wisplinghoff H., Bischoff T., Tallent S.M., Seifert H., Wenzel R.P., et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39 3 (2004) 309-317